Sonazoid Contrast Ultrasound Studies; Clinical Applications to Diagnosis of Liver Tumorous Diseases

摘要：

Sonazoid has been launched in Japanese market in 2007. During these five years, Sonazoid has been administered to more than 250,000 patients. There is no fatal side effect such as anaphylaxis shock.Application of Sonazoid is limited to diagnosis of liver tumorous diseases in terms of insurance reimbursement. This is because of that efficacy and safety of Sonazoid have been proved in clinical trials only in diagnosis of liver tumorous diseases.

作者: Fuminori Moriyasu

作者单位: Department of Gastroenterology & Hepatology Tokyo Medical University, Tokyo, Japan

会议类型: 国内会议

会议名称: 2012中国·北京超声医学学术大会

会议地点: 北京

会议语种:英文

页码: 96-97

在线出版日期: 2012-06-01（万方平台首次上网日期，不代表论文的发表时间）